Biotech Values

[wallstarb]

What's confusing about ARRY? Horrible balance sheet and $60m barely makes a dent in their outstanding liabilities/debt. Raising cash wouldnt suprise me going forward to pay down debt - many companies will be issuing equity to pay down debt as many have stared into the abyss of potential ch 11 and I think that like households you are goign to see a continuation of the delveraging - especially in small garbage comapnies that have feast or famine relationships with investors and credit markets.

I havent heard anything in particular regarding ARRY - but its not a name I bother asking about.